drugset / Trial / NCT05921370
Silodosin in Retrograde Intrarenal Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
Selective alpha-blockers have been used for the treatment of ureteric stones as medical expulsive therapy (MET). Recently they have been successfully used in passive ureteric dilatation before semirigid ureteroscopy. This study enables us to know the role of silodosin in ureteric dilatation to facilitate ureteral access sheath placement in Retrograde Intrarenal Surgery with flexible ureteroscopy.
Timeline
- Start
- 2023-04-04
- Primary completion
- 2023-07-01
- Completion
- 2023-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Silodosin | Unknown | 8 mg | — |